Traws Pharma, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -35.0% | -35.0% | -29.1% |
| FY2022 | -67.0% | -67.0% | -48.2% |
| FY2023 | -177.5% | -177.5% | -83.5% |
| FY2024 | 526.5% | 526.5% | -667.1% |
| FY2025 | -1,457.9% | -1,457.9% | 86.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -35.0% | -35.0% | -29.1% |
| FY2022 | -67.0% | -67.0% | -48.2% |
| FY2023 | -177.5% | -177.5% | -83.5% |
| FY2024 | 526.5% | 526.5% | -667.1% |
| FY2025 | -1,457.9% | -1,457.9% | 86.4% |